| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ARK GENOMIC REVOLUTION MULTI S | 532,743 | 506,975 |
| BRISTOL-MYERS SQUIBB CO | 140,257 | 134,850 |
| GREENLIGHT CAP RE CL A ORD | 182,774 | 364,500 |
| KINDER MORGAN INC | 151,424 | 274,900 |
| SCHWAB US BROAD MARKET | 88,100 | 393,450 |
| TRANSLATE BIO ORD SHS | 181,657 | 200 |
| VANGUARD FTSE EMERGING MARKETS | 294,547 | 403,200 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 7,978 | 7,978 | ||
| Postage/Delivery Service | 133 | 133 | ||
| State or Local Filing Fees | 25 | 25 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2025 | 1,300 |